Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases

Immunity

Volumn 21, Issue 4, 2004, Pages 539-550

  Diao, Hongyan ^a   Kon, Shigeyuki ^a   Iwabuchi, Kazuya ^a   Kimura, Chiemi ^a   Morimoto, Junko ^a   Ito, Daisuke ^a   Segawa, Tatsuya ^b   Maeda, Masahiro ^b   Hamuro, Junji ^c   Nakayama, Toshinori ^d   Taniguchi, Masaru ^e   Yagita, Hideo ^f   Van Kaer, Luc ^g   Onóe, Kazunori ^a   Denhardt, David ^h   Rittling, Susan ^h   Uede, Toshimitsu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Immuno Biological Laboratories Co Ltd   (Japan)

^c AJINOMOTO CO INC   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e RIKEN   (Japan)

^f JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; EPITOPE; NEUTRALIZING ANTIBODY; OSTEOPONTIN; THROMBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CELL FUNCTION; CELL SECRETION; CONTROLLED STUDY; HEPATITIS; LEUKOCYTE ACTIVATION; MALE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AMINO ACID MOTIFS; ANIMALS; BLOTTING, WESTERN; CELL MOVEMENT; CONCANAVALIN A; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEPATITIS, ANIMAL; IMMUNOHISTOCHEMISTRY; INTEGRINS; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE ACTIVATION; MALE; MICE; MODELS, IMMUNOLOGICAL; OSTEOPONTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; THROMBIN;

EID: 5644276291     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2004.08.012     Document Type: Article

References (57)

1. Arai M., Mochida S., Ohno A., Fujiwara K. Blood coagulation in the hepatic sinusoids as a contributing factor in liver injury following orthotopic liver transplantation in the rat. Transplantation. 62:1996;1398-1401
2. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., Rittling S.R., Denhardt D.T., Glimcher M.J., Cantor H. Eta-1 (osteopontin). an early component of type-1 (cell-mediated) immunity Science. 287:2000;860-864
3. Bajt M.L., Farhood A., Jaeschke H. Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. Am. J. Physiol. Gastrointest. Liver Physiol. 281:2001;G1188-G1195
4. Barry S.T., Ludbrook S.B., Murrison E., Horgan C.M. Analysis of the alpha4beta1 integrin-osteopontin interaction. Exp. Cell Res. 258:2000;342-351
5. Bayless K.J., Davis G.E. Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin. J. Biol. Chem. 276:2001;13483-13489
6. Bayless K.J., Meininger G.A., Scholtz J.M., Davis G.E. Osteopontin is a ligand for the alpha4beta1 integrin. J. Cell Sci. 111:1998;1165-1174
7. Bonder C.S., Ajuebor M.N., Zbytnuik L.D., Kubes P., Swain M.G. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J. Immunol. 172:2004;45-53
8. Brown K.E., Brunt E.M., Heinecke J.W. Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver. Am. J. Pathol. 159:2001;2081-2088
9. Burdin N., Brossay L., Koezuka Y., Smiley S.T., Grusby M.J., Gui M., Taniguchi M., Hayakawa K., Kronenberg M. Selective ability of mouse CD1 to present glycolipids. alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes J. Immunol. 161:1998;3271-3281
10. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 294:2001;1731-1735
11. Chen D., McKallip R.J., Zeytun A., Do Y., Lombard C., Robertson J.L., Mak T.W., Nagarkatti P.S., Nagarkatti M. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection. evidence for involvement of CD44 in activation-induced cell death J. Immunol. 166:2001;5889-5897
12. Chiba A., Oki S., Miyamoto K., Hashimoto H., Yamamura T., Miyake S. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum. 50:2004;305-313
13. Copple B.L., Moulin F., Hanumegowda U.M., Ganey P.E., Roth R.A. Thrombin and protease-activated receptor-1 agonists promote lipopolysaccharide-induced hepatocellular injury in perfused livers. J. Pharmacol. Exp. Ther. 305:2003;417-425
14. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., Kaneko Y., Koseki H., Kanno M., Taniguchi M. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1997;1623-1626
15. Diao J., Garces R., Richardson C.D. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev. 12:2001;189-205
16. Esmon C.T. Cell mediated events that control blood coagulation and vascular injury. Annu. Rev. Cell Biol. 9:1993;1-26
17. Faunce D.E., Sonoda K.H., Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166:2001;313-321
18. Feng L., Xia Y., Yoshimura T., Wilson C.B. Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J. Clin. Invest. 95:1995;1009-1017
19. Grone H.J., Grone E.F., Malle E. Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis. Lab. Invest. 82:2002;5-14
20. Iwabuchi K., Iwabuchi C., Tone S., Itoh D., Tosa N., Negishi I., Ogasawara K., Uede T., Onóe K. Defective development of NK1.1+ T-cell antigen receptor alphabeta+ cells in zeta-associated protein 70 null mice with an accumulation of NK1.1+ CD3- NK-like cells in the thymus. Blood. 97:2001;1765-1775
21. Jahng A.W., Maricic I., Pedersen B., Burdin N., Naidenko O., Kronenberg M., Koezuka Y., Kumar V. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194:2001;1789-1799
22. Jaruga B., Hong F., Sun R., Radaeva S., Gao B. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis. up-regulating eotaxins and IL-5 and recruiting leukocytes J. Immunol. 171:2003;3233-3244
23. Kaneko Y., Harada M., Kawano T., Yamashita M., Shibata Y., Gejyo F., Nakayama T., Taniguchi M. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191:2000;105-114
24. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., et al. CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science. 278:1997;1626-1629
25. Kitamura H., Iwakabe K., Yahata T., Nishimura S., Ohta A., Ohmi Y., Sato M., Takeda K., Okumura K., Van Kaer L., et al. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189:1999;1121-1128
26. Kon S., Yokosaki Y., Maeda M., Segawa T., Horikoshi Y., Tsukagoshi H., Rashid M.M., Morimoto J., Inobe M., Shijubo N., et al. Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences. J. Cell. Biochem. 84:2002;420-432
27. Leirisalo-Repo M. The present knowledge of the inflammatory process and the inflammatory mediators. Pharmacol. Toxicol. Suppl. 75:1994;1-3
28. Louis H., Le Moine O., Peny M.O., Quertinmont E., Fokan D., Goldman M., Deviere J. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology. 25:1997;1382-1389
29. Matsui Y., Rittling S.R., Okamoto H., Inobe M., Jia N., Shimizu T., Akino M., Sugawara T., Morimoto J., Kimura C., et al. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23:2003;1029-1034
30. McFarlane I.G. Pathogenesis of autoimmune hepatitis. Biomed. Pharmacother. 53:1999;255-263
31. Miyazawa Y., Tsutsui H., Mizuhara H., Fujiwara H., Kaneda K. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice. Hepatology. 27:1998;497-506
32. Morimoto J., Inobe M., Kimura C., Kon S., Diao H., Aoki M., Miyazaki T., Denhardt D.T., Rittling S., Uede T. Osteopontin affects the persistence of beta-glucan-induced hepatic granuloma formation and tissue injury through two distinct mechanisms. Int. Immunol. 16:2004;477-488
33. Moriyama H., Yamamoto T., Takatsuka H., Umezu H., Tokunaga K., Nagano T., Arakawa M., Naito M. Expression of macrophage colony-stimulating factor and its receptor in hepatic granulomas of Kupffer-cell-depleted mice. Am. J. Pathol. 150:1997;2047-2060
34. Nakamura K., Ito T., Yoneda M., Takamoto S., Nakade Y., Okamoto S., Okada M., Yokohama S., Aso K., Makino I. Antithrombin III prevents concanavalin A-induced liver injury through inhibition of macrophage inflammatory protein-2 release and production of prostacyclin in mice. J. Hepatol. 36:2002;766-773
35. Noto K., Kato K., Okumura K., Yagita H. Identification and functional characterization of mouse CD29 with a mAb. Int. Immunol. 7:1995;835-842
36. Ohshima S., Yamaguchi N., Nishioka K., Mima T., Ishii T., Umeshita-Sasai M., Kobayashi H., Shimizu M., Katada Y., Wakitani S., et al. Enhanced local production of osteopontin in rheumatoid joints. J. Rheumatol. 29:2002;2061-2067
37. O'Regan A.W., Nau G.J., Chupp G.L., Berman J.S. Osteopontin (Eta-1) in cell-mediated immunity. teaching an old dog new tricks Immunol. Today. 21:2000;475-478
38. Ramsaransing G., Teelken A., Prokopenko V.M., Arutjunyan A.V., De Keyser J. Low leucocyte myeloperoxidase activity in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 74:2003;953-955
39. Rittling S.R., Matsumoto H.N., McKee M.D., Nanci A., An X.R., Novick K.E., Kowalski A.J., Noda M., Denhardt D.T. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 13:1998;1101-1111
40. Singh N., Hong S., Scherer D.C., Serizawa I., Burdin N., Kronenberg M., Koezuka Y., Van Kaer L. Cutting edge. activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype J. Immunol. 163:1999;2373-2377
41. Smith L.L., Cheung H.K., Ling L.E., Chen J., Sheppard D., Pytela R., Giachelli C.M. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin. J. Biol. Chem. 271:1996;28485-28491
42. Smyth M.J., Crowe N.Y., Pellicci D.G., Kyparissoudis K., Kelly J.M., Takeda K., Yagita H., Godfrey D.I. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood. 99:2002;1259-1266
43. Sodek J., Ganss B., McKee M.D. Osteopontin. Crit. Rev. Oral Biol. Med. 11:2000;279-303
44. Steinman L., Zamvil S. Transcriptional analysis of targets in multiple sclerosis. Nat. Rev. Immunol. 3:2003;483-492
45. Takahashi F., Takahashi K., Okazaki T., Maeda K., Ienaga H., Maeda M., Kon S., Uede T., Fukuchi Y. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 24:2001;264-271
46. Takeda K., Hayakawa Y., Van Kaer L., Matsuda H., Yagita H., Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA. 97:2000;5498-5503
47. Tanaka K., Morimoto J., Kon S., Kimura C., Inobe M., Diao H., Hirschfeld G., Weiss J.M., Uede T. Effect of osteopontin alleles on beta-glucan-induced granuloma formation in the mouse liver. Am. J. Pathol. 164:2004;567-575
48. Taooka Y., Chen J., Yednock T., Sheppard D. The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J. Cell Biol. 145:1999;413-420
49. Tiegs G., Hentschel J., Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90:1992;196-203
50. Toyabe S., Seki S., Iiai T., Takeda K., Shirai K., Watanabe H., Hiraide H., Uchiyama M., Abo T. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J. Immunol. 159:1997;1537-1542
51. Tupin E., Nicoletti A., Elhage R., Rudling M., Ljunggren H.G., Hansson G.K., Berne G.P. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J. Exp. Med. 199:2004;417-422
52. Yamamoto N., Sakai F., Kon S., Morimoto J., Kimura C., Yamazaki H., Okazaki I., Seki N., Fujii T., Uede T. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J. Clin. Invest. 112:2003;181-188
53. Yasuda M., Hasunuma Y., Adachi H., Sekine C., Sakanishi T., Hashimoto H., Ra C., Yagita H., Okumura K. Expression and function of fibronectin binding integrins on rat mast cells. Int. Immunol. 7:1995;251-258
54. Yokasaki Y., Sheppard D. Mapping of the cryptic integrin-binding site in osteopontin suggests a new mechanism by which thrombin can regulate inflammation and tissue repair. Trends Cardiovasc. Med. 10:2000;155-159
55. Yokosaki Y., Matsuura N., Sasaki T., Murakami I., Schneider H., Higashiyama S., Saitoh Y., Yamakido M., Taooka Y., Sheppard D. The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J. Biol. Chem. 274:1999;36328-36334
56. Yoneyama H., Harada A., Imai T., Baba M., Yoshie O., Zhang Y., Higashi H., Murai M., Asakura H., Matsushima K. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J. Clin. Invest. 102:1998;1933-1941
57. Yumoto K., Ishijima M., Rittling S.R., Tsuji K., Tsuchiya Y., Kon S., Nifuji A., Uede T., Denhardt D.T., Noda M. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc. Natl. Acad. Sci. USA. 99:2002;4556-4561